Log in to save to my catalogue

Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1...

Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_21096228

Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study

About this item

Full title

Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study

Publisher

Kidlington: Elsevier Ltd

Journal title

The Lancet (British edition), 2009-09, Vol.374 (9693), p.912-920

Language

English

Formats

Publication information

Publisher

Kidlington: Elsevier Ltd

More information

Scope and Contents

Contents

Summary Background Stem-cell transplantation can cure primary immunodeficiencies. However, in patients with pre-existing organ toxicity, patients younger than 1 year, and those with DNA or telomere repair disorders, chemotherapy-based conditioning is poorly tolerated and results in major morbidity and mortality. We tested a novel antibody-based min...

Alternative Titles

Full title

Haemopoietic stem-cell transplantation with antibody-based minimal-intensity conditioning: a phase 1/2 study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_21096228

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_21096228

Other Identifiers

ISSN

0140-6736

E-ISSN

1474-547X

DOI

10.1016/S0140-6736(09)60945-4

How to access this item